Mississippi House Bill 1031 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Failed on February 28 2017 - 100% progression
Action: 2017-02-28 - Died In Committee
Text: Latest bill text (Engrossed) [HTML]

An Act To Amend Section 41-29-113, Mississippi Code Of 1972, To Revise Schedule I To Include Ah-7921, Butyryl Fentanyl And Beta-hydroxythiofentanyl; To Amend Sections 41-29-115 And 41-29-117, Mississippi Code Of 1972, To Exclude Pentazocine, A Schedule Iv Drug, From Listing On Schedules Ii And Iii; To Amend Section 41-29-119, Mississippi Code Of 1972, To Revise Schedule Iv To Include Eluxadoline; To Amend Section 41-29-121, Mississippi Code Of 1972, To Revise Schedule V To Include Brivaracetam; And For Related Purposes.

Drug Schedules I, II and III; revise.

Rep. Patricia Willis [R]

Rep. Deborah Butler Dixon [D]

2017-02-07 - House - House Passed (Y: 120 N: 1 NV: 1 Abs: 0) [PASS]

Date	Chamber	Action
2017-02-28	Senate	Died In Committee
2017-02-15	Senate	Referred To Drug Policy
2017-02-08	House	Transmitted To Senate
2017-02-07	House	Passed
2017-01-25	House	Title Suff Do Pass
2017-01-16	House	Referred To Drug Policy

Type	Source
Summary	https://billstatus.ls.state.ms.us/2017/pdf/history/HB/HB1031.xml
Text	https://billstatus.ls.state.ms.us/documents/2017/html/HB/1000-1099/HB1031IN.htm
Text	https://billstatus.ls.state.ms.us/documents/2017/html/HB/1000-1099/HB1031PS.htm
Roll Call	https://billstatus.ls.state.ms.us/2017/pdf/votes/house/0360016.pdf